Managing Pharmaceuticals in International Health:
"One third of the world's population lack effective access to quality assured essential medicines used rationally". When WHO first made this statement fifteen years ago, there was general concern that medical miracles such as antibiotics, antiparasitic medicines, vaccines and anal ge...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Basel
Birkhäuser Basel
2004
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | "One third of the world's population lack effective access to quality assured essential medicines used rationally". When WHO first made this statement fifteen years ago, there was general concern that medical miracles such as antibiotics, antiparasitic medicines, vaccines and anal gesics would not be available to many people. Today, the proportion of those lack ing access is lower in Asia and Latin America and higher in Africa but there are probably about two billion people in this situation. This book describes the many problems involved, and then puts together possible solutions based on country expe riences in a comprehensive and coherent manner. Many people lack access to essential medicines because they and their countries are poor, and because of inefficiencies in their health systems. We know that in low and middle income countries between 25 and 40 per cent of health expenditure is on medicines, and that most of that expenditure is out of pocket. Often this amounts to less than US $ 2 per head per year! In contrast, high income countries spend only 8 to 15 per cent of health expenditure on medicines, and this is mostly paid for by health insurance or social security funds. High income country expen diture may be over US $ 400 per person per year! So managing the scanty resources available in low income countries becomes all the more important |
Beschreibung: | 1 Online-Ressource (XIV, 232 p. 103 illus) |
ISBN: | 9783034879132 |
DOI: | 10.1007/978-3-0348-7913-2 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046143628 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s2004 |||| o||u| ||||||eng d | ||
020 | |a 9783034879132 |9 978-3-0348-7913-2 | ||
024 | 7 | |a 10.1007/978-3-0348-7913-2 |2 doi | |
035 | |a (ZDB-2-SME)978-3-0348-7913-2 | ||
035 | |a (OCoLC)1119016429 | ||
035 | |a (DE-599)BVBBV046143628 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 613 |2 23 | |
082 | 0 | |a 614 |2 23 | |
084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
100 | 1 | |a Anderson, Stuart C. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Managing Pharmaceuticals in International Health |c by Stuart C. Anderson, Reinhard Huss, Robert S. Summers, Karin A. Wiedenmayer |
264 | 1 | |a Basel |b Birkhäuser Basel |c 2004 | |
300 | |a 1 Online-Ressource (XIV, 232 p. 103 illus) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a "One third of the world's population lack effective access to quality assured essential medicines used rationally". When WHO first made this statement fifteen years ago, there was general concern that medical miracles such as antibiotics, antiparasitic medicines, vaccines and anal gesics would not be available to many people. Today, the proportion of those lack ing access is lower in Asia and Latin America and higher in Africa but there are probably about two billion people in this situation. This book describes the many problems involved, and then puts together possible solutions based on country expe riences in a comprehensive and coherent manner. Many people lack access to essential medicines because they and their countries are poor, and because of inefficiencies in their health systems. We know that in low and middle income countries between 25 and 40 per cent of health expenditure is on medicines, and that most of that expenditure is out of pocket. Often this amounts to less than US $ 2 per head per year! In contrast, high income countries spend only 8 to 15 per cent of health expenditure on medicines, and this is mostly paid for by health insurance or social security funds. High income country expen diture may be over US $ 400 per person per year! So managing the scanty resources available in low income countries becomes all the more important | ||
650 | 4 | |a Public Health | |
650 | 4 | |a Medicine/Public Health, general | |
650 | 4 | |a Medicine | |
700 | 1 | |a Huss, Reinhard |4 aut | |
700 | 1 | |a Summers, Robert S. |4 aut | |
700 | 1 | |a Wiedenmayer, Karin A. |4 aut | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783764366018 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034879149 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-0348-7913-2 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031523812 | ||
966 | e | |u https://doi.org/10.1007/978-3-0348-7913-2 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180477947412480 |
---|---|
any_adam_object | |
author | Anderson, Stuart C. Huss, Reinhard Summers, Robert S. Wiedenmayer, Karin A. |
author_facet | Anderson, Stuart C. Huss, Reinhard Summers, Robert S. Wiedenmayer, Karin A. |
author_role | aut aut aut aut |
author_sort | Anderson, Stuart C. |
author_variant | s c a sc sca r h rh r s s rs rss k a w ka kaw |
building | Verbundindex |
bvnumber | BV046143628 |
classification_rvk | QR 525 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-0348-7913-2 (OCoLC)1119016429 (DE-599)BVBBV046143628 |
dewey-full | 613 614 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 613 - Personal health & safety 614 - Forensic medicine; incidence of disease |
dewey-raw | 613 614 |
dewey-search | 613 614 |
dewey-sort | 3613 |
dewey-tens | 610 - Medicine and health |
discipline | Wirtschaftswissenschaften Medizin |
doi_str_mv | 10.1007/978-3-0348-7913-2 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03041nmm a2200469zc 4500</leader><controlfield tag="001">BV046143628</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2004 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783034879132</subfield><subfield code="9">978-3-0348-7913-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-0348-7913-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-0348-7913-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119016429</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046143628</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">613</subfield><subfield code="2">23</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Anderson, Stuart C.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Managing Pharmaceuticals in International Health</subfield><subfield code="c">by Stuart C. Anderson, Reinhard Huss, Robert S. Summers, Karin A. Wiedenmayer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">Birkhäuser Basel</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 232 p. 103 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"One third of the world's population lack effective access to quality assured essential medicines used rationally". When WHO first made this statement fifteen years ago, there was general concern that medical miracles such as antibiotics, antiparasitic medicines, vaccines and anal gesics would not be available to many people. Today, the proportion of those lack ing access is lower in Asia and Latin America and higher in Africa but there are probably about two billion people in this situation. This book describes the many problems involved, and then puts together possible solutions based on country expe riences in a comprehensive and coherent manner. Many people lack access to essential medicines because they and their countries are poor, and because of inefficiencies in their health systems. We know that in low and middle income countries between 25 and 40 per cent of health expenditure is on medicines, and that most of that expenditure is out of pocket. Often this amounts to less than US $ 2 per head per year! In contrast, high income countries spend only 8 to 15 per cent of health expenditure on medicines, and this is mostly paid for by health insurance or social security funds. High income country expen diture may be over US $ 400 per person per year! So managing the scanty resources available in low income countries becomes all the more important</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine/Public Health, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huss, Reinhard</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Summers, Robert S.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wiedenmayer, Karin A.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783764366018</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034879149</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-0348-7913-2</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031523812</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-0348-7913-2</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV046143628 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:23Z |
institution | BVB |
isbn | 9783034879132 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031523812 |
oclc_num | 1119016429 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XIV, 232 p. 103 illus) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 2004 |
publishDateSearch | 2004 |
publishDateSort | 2004 |
publisher | Birkhäuser Basel |
record_format | marc |
spelling | Anderson, Stuart C. Verfasser aut Managing Pharmaceuticals in International Health by Stuart C. Anderson, Reinhard Huss, Robert S. Summers, Karin A. Wiedenmayer Basel Birkhäuser Basel 2004 1 Online-Ressource (XIV, 232 p. 103 illus) txt rdacontent c rdamedia cr rdacarrier "One third of the world's population lack effective access to quality assured essential medicines used rationally". When WHO first made this statement fifteen years ago, there was general concern that medical miracles such as antibiotics, antiparasitic medicines, vaccines and anal gesics would not be available to many people. Today, the proportion of those lack ing access is lower in Asia and Latin America and higher in Africa but there are probably about two billion people in this situation. This book describes the many problems involved, and then puts together possible solutions based on country expe riences in a comprehensive and coherent manner. Many people lack access to essential medicines because they and their countries are poor, and because of inefficiencies in their health systems. We know that in low and middle income countries between 25 and 40 per cent of health expenditure is on medicines, and that most of that expenditure is out of pocket. Often this amounts to less than US $ 2 per head per year! In contrast, high income countries spend only 8 to 15 per cent of health expenditure on medicines, and this is mostly paid for by health insurance or social security funds. High income country expen diture may be over US $ 400 per person per year! So managing the scanty resources available in low income countries becomes all the more important Public Health Medicine/Public Health, general Medicine Huss, Reinhard aut Summers, Robert S. aut Wiedenmayer, Karin A. aut Erscheint auch als Druck-Ausgabe 9783764366018 Erscheint auch als Druck-Ausgabe 9783034879149 https://doi.org/10.1007/978-3-0348-7913-2 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Anderson, Stuart C. Huss, Reinhard Summers, Robert S. Wiedenmayer, Karin A. Managing Pharmaceuticals in International Health Public Health Medicine/Public Health, general Medicine |
title | Managing Pharmaceuticals in International Health |
title_auth | Managing Pharmaceuticals in International Health |
title_exact_search | Managing Pharmaceuticals in International Health |
title_full | Managing Pharmaceuticals in International Health by Stuart C. Anderson, Reinhard Huss, Robert S. Summers, Karin A. Wiedenmayer |
title_fullStr | Managing Pharmaceuticals in International Health by Stuart C. Anderson, Reinhard Huss, Robert S. Summers, Karin A. Wiedenmayer |
title_full_unstemmed | Managing Pharmaceuticals in International Health by Stuart C. Anderson, Reinhard Huss, Robert S. Summers, Karin A. Wiedenmayer |
title_short | Managing Pharmaceuticals in International Health |
title_sort | managing pharmaceuticals in international health |
topic | Public Health Medicine/Public Health, general Medicine |
topic_facet | Public Health Medicine/Public Health, general Medicine |
url | https://doi.org/10.1007/978-3-0348-7913-2 |
work_keys_str_mv | AT andersonstuartc managingpharmaceuticalsininternationalhealth AT hussreinhard managingpharmaceuticalsininternationalhealth AT summersroberts managingpharmaceuticalsininternationalhealth AT wiedenmayerkarina managingpharmaceuticalsininternationalhealth |